[{"id":"e6de9ac1-93ef-4478-a4b2-f0781d7a19e6","acronym":"","url":"https://clinicaltrials.gov/study/NCT01173887","created_at":"2021-01-18T04:40:58.159Z","updated_at":"2024-07-02T16:37:23.941Z","phase":"Phase 2","brief_title":"Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15","source_id_and_acronym":"NCT01173887","lead_sponsor":"Kyowa Kirin Co., Ltd.","biomarkers":" CCR4","pipe":"","alterations":" ","tags":["CCR4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e carboplatin • doxorubicin hydrochloride • cyclophosphamide • Poteligeo (mogamulizumab-kpkc) • Cymerin (ranimustine) • vindesine"],"overall_status":"Completed","enrollment":" Enrollment 44","initiation":"Initiation: 07/01/2010","start_date":" 07/01/2010","primary_txt":" Primary completion: 04/01/2012","primary_completion_date":" 04/01/2012","study_txt":" Completion: 04/01/2012","study_completion_date":" 04/01/2012","last_update_posted":"2017-03-30"}]